Deerfield Management Company, L.P. (Series C) Bio Techne Corp Transaction History
Deerfield Management Company, L.P. (Series C)
- $5.38 Billion
- Q3 2024
A detailed history of Deerfield Management Company, L.P. (Series C) transactions in Bio Techne Corp stock. As of the latest transaction made, Deerfield Management Company, L.P. (Series C) holds 11,531 shares of TECH stock, worth $770,962. This represents 0.02% of its overall portfolio holdings.
Number of Shares
11,531
Previous 13,526
14.75%
Holding current value
$770,962
Previous $969,000
4.95%
% of portfolio
0.02%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding TECH
# of Institutions
602Shares Held
151MCall Options Held
195KPut Options Held
53.2K-
Vanguard Group Inc Valley Forge, PA18.3MShares$1.22 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY15MShares$1 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD9.42MShares$630 Million0.09% of portfolio
-
State Street Corp Boston, MA6.4MShares$428 Million0.02% of portfolio
-
Morgan Stanley New York, NY4.66MShares$311 Million0.03% of portfolio
About BIO-TECHNE Corp
- Ticker TECH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,222,600
- Market Cap $2.62B
- Description
- Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...